Atlas Venture Fund X, L.P. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
19
Insider Sells Sum
$89.94M

Insider Activity of Atlas Venture Fund X, L.P.

Biography of Atlas Venture Fund X, L.P.

No biography is available at this moment.

2024-03-13SaleKymera Therapeutics, Inc.
KYMR
10 percent owner
139,255
0.2271%
$42.23$5.88M-3.95%
2024-03-12SaleKymera Therapeutics, Inc.
KYMR
10 percent owner
162,918
0.2674%
$41.98$6.84M-2.86%
2024-03-11SaleKymera Therapeutics, Inc.
KYMR
10 percent owner
51,184
0.0849%
$42.85$2.19M-3.78%
2024-01-23SaleDisc Medicine, Inc.
IRON
10 percent owner
150,000
0.5374%
$67.65$10.15M-26.03%
2024-01-10SaleDisc Medicine, Inc.
IRON
10 percent owner
50,000
0.1695%
$64.00$3.2M-23.63%
2023-12-14SaleDisc Medicine, Inc.
IRON
10 percent owner
51,374
0.1586%
$58.28$2.99M-16.22%
2023-12-13SaleDisc Medicine, Inc.
IRON
10 percent owner
8,871
0.0282%
$60.00$532,222-17.18%
2023-12-12SaleDisc Medicine, Inc.
IRON
10 percent owner
129,918
0.4321%
$62.80$8.16M-18.15%
2023-08-15SaleDisc Medicine, Inc.
IRON
10 percent owner
184,000
0.5106%
$52.40$9.64M-10.54%
2023-08-14SaleDisc Medicine, Inc.
IRON
10 percent owner
175,000
0.4874%
$52.59$9.2M-7.02%
2023-01-12SaleKymera Therapeutics, Inc.
KYMR
director
98,720
0.153%
$30.29$2.99M-27.04%
2023-01-11SaleKymera Therapeutics, Inc.
KYMR
director
27,754
0.0478%
$29.96$831,510-18.06%
2022-12-15SaleKymera Therapeutics, Inc.
KYMR
director
3,278
0.0061%
$30.00$98,340-12.26%
2022-12-14SaleKymera Therapeutics, Inc.
KYMR
director
378,966
0.6933%
$31.37$11.89M-17.35%
2022-11-03SaleKymera Therapeutics, Inc.
KYMR
director
96,397
0.1616%
$30.00$2.89M-11%
2022-11-02SaleKymera Therapeutics, Inc.
KYMR
director
123,619
0.223%
$30.02$3.71M-4.28%
2022-11-01SaleKymera Therapeutics, Inc.
KYMR
director
77,030
0.136%
$30.60$2.36M-8.02%
2022-10-31SaleKymera Therapeutics, Inc.
KYMR
director
120,622
0.2076%
$30.23$3.65M-8.8%
2022-10-28SaleKymera Therapeutics, Inc.
KYMR
director
91,050
0.1573%
$30.00$2.73M-7.52%
Total: 19
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.